Leo Grady, PhD, is Chief Executive Officer of Paige, the leading computational pathology company focused on building artificial intelligence (AI) to transform the clinical diagnosis and treatment of cancer. Leo is a seasoned healthcare technology professional, with 15+ years of experience in prototyping, developing and bringing to market advanced machine learning, computer vision and medical imaging technologies and products. Since becoming CEO of Paige, Leo has led the company to receive Breakthrough Device designation by the U.S. Food and Drug Administration, the first such designation for AI in cancer diagnosis publicly announced by any company. Prior to joining Paige, Leo was the SVP of Engineering for HeartFlow, where he led full stack technology and product development efforts for HeartFlow’s cardiovascular software and drove HeartFlow’s IP portfolio. Before that, Leo served in a variety of leadership roles at Siemens. Leo is the author of two published books, over 100 peer-reviewed journal and conference papers and has over 300 issued or pending patents worldwide. Winner of the 2012 Edison Patent Award in medical imaging, he was inducted as a Fellow in the American Institute for Medical and Biological Engineering in 2014. Leo received the B.Sc. degree in electrical engineering at the University of Vermont and a Ph.D. in cognitive and neural systems fromBoston University. Multiple members of Leo’s family emigrated in the 19th century from counties Mayo, Clare and Galway to Pennsylvania. Leo’s family shares a love for  Irish music, his daughter studied Irish step dancing, and he lives with his two children in Connecticut. ♦